DNS HMB ¥¿¥Ö¥ì¥Ã¥È 180γ¡Ê30²óʬ¡Ë

Äê²Á 2,376±ß(ÆâÀÇ)
²ñ°÷²Á³Ê ²ñ°÷ÆÃÊ̲Á³Ê

²ñ°÷¤Î¤ß¹ØÆþ¤Ç¤­¤Þ¤¹
ºÇ®¤Ç¥Ç¥«¤¯¤Ê¤ì¡£
HMB¤Ï¿ÈÂΤŤ¯¤ê¤Ë´Ø¤·Â¿¤¯¤Î¥¨¥Ó¥Ç¥ó¥¹¤ò¤â¤Ä±ÉÍÜÁǤǤ¢¤ê¡¢¸þ¾å¿´¤ò»ý¤Ä¥¦¥©¥ê¥¢¡¼¤Ë¤Ï¤¼¤Ò¤È¤â»È¤Ã¤Æ¤â¤é¤¤¤¿¤¤¡£

HMB¤ò´Þ¤à¾¦Éʤˤϡ¢¤¤¤ï¤æ¤ë¥À¥¤¥¨¥Ã¥È¸þ¤±¤Î¾¦Éʤ䡢³¤³°¥Ö¥é¥ó¥ÉÀ½Éʤ⿤¯¡¢¿®ÍêÀ­¤ä°ÂÁ´À­¤Ëµ¿Ìä¤ò»Ä¤¹¤â¤Î¤â¤¢¤ë¡£

¿¤¯¤Î¸þ¾å¿´¤¢¤ë¿Í¤Ë¡¢¤³¤Î¶¯ÎϤÊHMB¤òÀµ¤·¤¯»È¤Ã¤Æ¤â¤é¤¤¤¿¤¤¡£

¤½¤ó¤Ê»×¤¤¤«¤é¡¢DNS¤È¤·¤Æ¡¢¡ÖHMB¡×¤òȯÇ䤷¤¿¡£

HMB¤ò³èÍѤ·¡¢ºÇ®¤Ç¥Ç¥«¤¯¤Ê¤ì¡£

HMB¤È¤Ï
20171219.jpg

HMB¤È¤Ï¡¢BCAA ¡Öʬ´ôº¿¥¢¥ß¥Î»À¡×¤Î¥í¥¤¥·¥ó¤ÎÂå¼Õʪ¤Ç¦Â-¥Ò¥É¥í¥­¥·¦Â-¥á¥Á¥ë¥Ö¥Á¥ì¡¼¥È¡Ê±Ñ¡§3-Hydroxy 3-MethylButyrate¡¡¡Ë¤òά¤·¤ÆHMB¤È¸Æ¤Ð¤ì¤Æ¤¤¤ë¡£

¤½¤·¤Æ¡¢¥¤¥ó¥¿¡¼¥Í¥Ã¥ÈÄÌÈΤòÃæ¿´¤Ë¡¢"¥×¥í¥Æ¥¤¥ó¤Î»þÂå¤Ï½ª¤ï¤Ã¤¿"¡¡"¥À¥¤¥¨¥Ã¥È¤ÎºÇ½ªÊ¼´ï"¡¡"ͭ̾¥¿¥ì¥ó¥È¡»¡»¡»°¦ÍѤÎ"¤Ê¤É¡¢ÍÍ¡¹¤Ê¥­¥ã¥Ã¥Á¥Õ¥ì¡¼¥º¤È¤È¤â¤Ë¿¤¯¤ÎÀ½Éʤ¬ÈÎÇ䤵¤ì¤Æ¤¤¤ëHMB¡£

¤·¤«¤·¡¢¥¤¥á¡¼¥¸Àè¹Ô¤¹¤ëÃæ¡¢¼ÂºÝ¾Ü¤·¤¯¾¦Éʤò¤ß¤ë¤È¡¢ÇÛ¹çÎ̤äÀ®Ê¬¾ðÊó¤Îµ­ºÜ¤¬Ë³¤·¤¤¤â¤Î¤ä¡¢»ÈÍÑÊýË¡¤Ëµ¿Ì䤬À¸¤¸¤ëÆâÍÆ¤â»¶¸«¤µ¤ì¤ë¡£

HMB¤Ë¤ÏÂ礭¤¯£³¤Ä¤Îµ¡Ç½¤¬¤¢¤ê¡¢¶Ú¥¿¥ó¥Ñ¥¯¤Î¹çÀ®Â¥¿Ê¡¢¶Ú¥¿¥ó¥Ñ¥¯¤Îʬ²òÍÞÀ©¡Ê¢¨1¡¢¢¨2¡¢¢¨3¡Ë¡¡¶ÚºÙ˦¤ÎºÙ˦Ëì¤Î°ÂÄê²½¡Ê¢¨4¡¢¢¨5¡Ë¡£¤Ä¤Þ¤ê¡¢¿ÈÂκî¤ê¤ò¶¯ÎϤ˥µ¥Ý¡¼¥È¤¹¤ë¤Î¤¬HMB¡£¤¿¤À¡¢ËÜÅö¤ËHMB¤À¤±°û¤ó¤Ç¤¤¤¤¤ì¤Ð¤è¤¤¤Î¤À¤í¤¦¤«¡¦¡¦¡¦¡£

HMB¤Î¼ç¤Ê£³¤Ä¤ÎƯ¤­¤Ë¤Ä¤¤¤Æ¡¢¤¤¤¯¤Ä¤«¤Î¥¨¥Ó¥Ç¥ó¥¹¤Ë´ð¤Å¤­ÀâÌÀ¤¹¤ë¡£

¶Ú¥¿¥ó¥Ñ¥¯¤Î¹çÀ®Â¥¿Ê
¶Ú¥¿¥ó¥Ñ¥¯¤Î¹çÀ®Â¥¿Ê¡¦Ê¬²òÍÞÀ©¤Ç·ç¤«¤»¤Ê¤¤¤Î¤¬¡¢"¥·¥°¥Ê¥ëÅÁã"¤È¤¤¤¦³µÇ°¤À¡£
"¥·¥°¥Ê¥ëÅÁã"¤È¤Ï¡¢ÂÎÆâ¤Ç´Ø·¸¸Ä½ê¤Ø»Ø¼¨¤ò½Ð¤¹¿®¹æÅÁã·ÐÏ©¤ò¼¨¤¹¤â¤Î¡£HMB¤Ï¡¢¶Ú¥¿¥ó¥Ñ¥¯¤Î¹çÀ®¤Èʬ²òÍÞÀ©¤Î"¥·¥°¥Ê¥ëÅÁã"¤Ë´ØÍ¿¤¹¤ë¡£

¶Ú¥¿¥ó¥Ñ¥¯¹çÀ®¤ÎÅÁã·ÐÏ©¤Î°ì¤Ä¤Ë¡ÖmTOR (mammalian target of rapamycin)¡×¤È¸Æ¤Ð¤ì¤ë¹ÚÁǤò²ð¤·¤¿·ÐÏ©¤¬¤¢¤ê¡¢HMB¤Ï¤³¤Î·ÐÏ©¤Î¥¹¥¤¥Ã¥Á¤òON¤Ë¤¹¤ë¤³¤È¤Ë¤è¤ê¶Ú¥¿¥ó¥Ñ¥¯¤Î¹çÀ®¤òÂ¥¿Ê¤µ¤»¤ë¡£¡Ê¢¨1¡Ë

¶Ú¥¿¥ó¥Ñ¥¯¤Îʬ²òÍÞÀ©
ʬ²ò¤ÎÍÞÀ©¤Ï¡¢¥æ¥Ó¥­¥Á¥ó¡¦¥×¥í¥Æ¥¢¥½¡¼¥à·Ï¤È¤¤¤¦ÅÁã·ÐÏ©¤¬¤¢¤ê¡¢HMB¤Ï¤³¤ÎÅÁã·ÐÏ©¤Î¥¹¥¤¥Ã¥Á¤òOFF¤Ë¤¹¤ë¤³¤È¤Ç¡¢¶Ú¥¿¥ó¥Ñ¥¯¤Îʬ²ò¤òÍÞÀ©¤¹¤ë¤È¤¤¤¦µ¡Ç½¤ò¤â¤Ä¡£¡Ê¢¨2¡¢¢¨3¡Ë¡£

¶ÚºÙ˦¤ÎºÙ˦Ëì¤Î°ÂÄê
¶ÚºÙ˦¤ÎºÙ˦Ëì¤Î°ÂÄê²½¤Ë¤Ä¤¤¤Æ¤Ï¡¢¥³¥ì¥¹¥Æ¥í¡¼¥ë¤Ë¤Ä¤¤¤Æ¿¨¤ì¤ëɬÍפ¬¤¢¤ë¡£
¥³¥ì¥¹¥Æ¥í¡¼¥ë¤Ï¡¢¥¹¥Æ¥í¥¤¥É¥Û¥ë¥â¥ó¤äºÙ˦Ëì¤Î¹çÀ®¤ËÍѤ¤¤é¤ì¤ë½ÅÍפÊÀ®Ê¬¤À¤¬¡¢Â»½ý¤·¤¿¶ÚÆùÁÈ¿¥¤Ç¤Ï¡¢½½Ê¬¤Ê¥³¥ì¥¹¥Æ¥í¡¼¥ë¤¬¹çÀ®¤µ¤ì¤Ê¤¤¤È¹Í¤¨¤é¤ì ¤Æ¤¤¤ë¡Ê¢¨4¡Ë¡£HMB¤Ï¡¢ÂÎÆâ¤Ç¤Î¥³¥ì¥¹¥Æ¥í¡¼¥ë¹çÀ®¤Ë¤ª¤¤¤Æ¶ÚÆùÁÈ¿¥Æâ¤Î¥³¥ì¥¹¥Æ¥í¡¼¥ë¹çÀ®¤òÂ¥¿Ê¤·¡¢¹çÀ®¤µ¤ì¤¿¥³¥ì¥¹¥Æ¥í¡¼¥ë¤Ï¡¢Â»½ý¤·¤¿¶ÚºÙ˦¤Î ºÙ˦Ëì¤ÎºÆÀ¸¤ËÍøÍѤµ¤ì¡¢¶ÚÆùÁÈ¿¥¤¬Â®¤ä¤«¤Ë°ÂÄê²½¤µ¤ì¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¤ÈÊó¹ð¤µ¤ì¤Æ¤¤¤ë¡£¡Ê¢¨4¡¢¢¨5¡Ë

¤³¤Î¤è¤¦¤ËHMB¤Ï¡¢¶Ú¤Î¹çÀ®¡¦Ê¬²ò¤Ë´Ø¤¹¤ë¥¹¥¤¥Ã¥Á¤ÈºÙ˦Ëì¤Î°ÂÄ꤬¼ç¤ÊÌò³ä¤Ç¤¢¤ê´ÖÀÜŪ¤Ê¤â¤Î¡£
¸Î¤ËHMBñÂΤÎÀݼè¤è¤ê¤â¡¢¥×¥í¥Æ¥¤¥óÅù¤È¤ÎÊ»ÍѤ¬¤è¤êÁê¾è¸ú²Ì¤òÆÀ¤é¤ì¤ë¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¡£

¡Ú Reference ¡Û
¢¨1 Am J Physiol Endocrinol Metab 293;E923-E931, 2007
¢¨2 Med Sci Sports Exerc 38¡ÊSuppl 5¡Ë; S550-S551, 2006.
¢¨3 Cancer Res 65; 277-283, 2005.
¢¨4 J Nutr 130; 1937-1945, 2000.
¢¨5 J Appl Physiol 81; 2095-2104, 1996.

¡ù±ÉÍܲÁ
¡Ú1¿©(6γ)¤¢¤¿¤ê¡Û
¥¨¥Í¥ë¥®¡¼¡§6.6kcal¡¢¤¿¤ó¤Ñ¤¯¼Á¡§0g¡¢»é¼Á¡§0.1g¡¢Ãº¿å²½Êª¡§1.0g¡¢¿©±öÁêÅöÎÌ¡§0.005g¡¢HMB¥«¥ë¥·¥¦¥à¡§1,500­Ó¡ÊHMB¤È¤·¤Æ1,200­Ó¡Ë

¡ù¸¶ºàÎÁ
HMB¥«¥ë¥·¥¦¥à¡¢´Ô¸µÇþ²êÅü¿å°»¡¿·ë¾½¥»¥ë¥í¡¼¥¹¡¢¥¹¥Æ¥¢¥ê¥ó»À¥«¥ë¥·¥¦¥à¡¢¥ê¥ó»À¥«¥ë¥·¥¦¥à¡¢Èùγ»À²½¥±¥¤ÁÇ¡¢¥°¥ê¥»¥ê¥ó»éËûÀ¥¨¥¹¥Æ¥ë

¡ù¤ª¾¤¤·¾å¤¬¤êÊý
HMB¥¿¥Ö¥ì¥Ã¥È¤Ï¡¢¿å¤Ê¤É¤È°ì½ï¤Ë1Æü6γ¡Á12γ¤òÌܰ¤ˤª¾¤¤·¾å¤¬¤ê¤¯¤À¤µ¤¤¡£

¡ù¿ä¾©Àݼ西¥¤¥ß¥ó¥°
¡¦¤¤¤Ä¤Ç¤â

¡ù¾¦ÉʾðÊó
À½Â¤¹©¾ì¡§¹ñÆâ¤ÎGMP¤â¤·¤¯¤ÏFSSC¼èÆÀ¹©¾ì¤Ë¤ÆÀ½Â¤
¾ÞÌ£´ü¸Â¡§À½Â¤Æü¤è¤ê12¥ö·î
¤´»ÈÍѾå¤ÎÃí°Õ¡§
¸¶ºàÎÁ¤ò»²¾È¤Î¾å¡¢¿©Êª¥¢¥ì¥ë¥®¡¼¤Î¿´ÇۤΤ¢¤ëÊý¤Ï¤´»ÈÍѤò¤ª¹µ¤¨¤¯¤À¤µ¤¤¡£
¤ª»Ò¤µ¤Þ¤Î¼ê¤ÎÆÏ¤«¤Ê¤¤¤È¤³¤í¤ËÊݴɤ·¤Æ¤¯¤À¤µ¤¤¡£
³«Éõ¸å¤Ï¤·¤Ã¤«¤ê³¸¤òÊĤᡢ¤Ê¤ë¤Ù¤¯¤ªÁá¤á¤Ë¤ª¾¤¤·¾å¤¬¤ê¤¯¤À¤µ¤¤¡£
ÂμÁ¤Ë¤è¤ê¤Þ¤ì¤Ë¿ÈÂΤˤ¢¤ï¤Ê¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£¤½¤Î¾ì¹ç¤Ï»ÈÍѤòÃæ»ß¤·¤Æ¤¯¤À¤µ¤¤¡£
¼çÍ×À®Ê¬¤È¸¶»º¹ñ¡§HMB¥«¥ë¥·¥¦¥à¡¿ÆüËÜ

Á´¤Æ¤Î¥¢¥¹¥ê¡¼¥È¤ò±þ±ç¤¹¤ë¡¢·ã°Â¥×¥í¥Æ¥¤¥ó¡¦¥µ¥×¥ê¥á¥ó¥È ¥ª¥ó¥é¥¤¥ó¥·¥ç¥Ã¥×

·ã°Â¥×¥í¥Æ¥¤¥ó¡¦¥µ¥×¥ê¥á¥ó¥È¥ª¥ó¥é¥¤¥ó¥·¥ç¥Ã¥×¡¡¥È¥Ã¥×¤Ø